全球脑植入物市场于2020年估价为47.3亿美元,预计预测期内的CAGR增长9.1%。神经疾病的普遍性是一个主要的市场驱动因素。帕金森病,阿尔茨海默病和其他神经疾病的增加的注册案件已经使世界各地政府投资于研究试验和医疗设施,以寻找所有这些条件的治疗方法。
了解有关此报告的更多信息:request for sample pages
The increasing geriatric population across the globe has also escalated the demand for brain implants. In addition, the launch of cost-effective and technologically advanced treatment technologies could result in substantial market expansion in the coming years.
神经疾病的渐渐增长是植入物的重要市场司机。根据世界卫生组织的说法,神经系统疾病占全球疾病负担的6.3%及其最大死因之一,发达经济体的13.2%的死亡人数和低收入国家的16.8%。
Growth Drivers
近年来,脑植入经历了巨大的转变,随着脑植入的新技术的出现,最近由Medtronic推出的MRI安全。NeuralInk 2019年Elon Musk推出的初创公司正在努力开发植入物,该植入物能够通过AI将人类脑与计算机接口纳入,所有这些发展将推动到未来几十年中脑植入物的增长。
Many new devices are getting launched across the globe after getting approval from the regulatory agencies. For instance, WaveWriter Alpha Spinal Cord Stimulator Systems received CE approval for its launch in Europe, in 2020. The system is developed by Boston Scientific and is used in the treatment of chronic pain and in stimulating the peripheral nerve of the trunk.
There is also an increase in the collaborations and acquisitions related to brain implants owing to its increasing demand to bring new technologies to the market. The University of Washington has entered into collaboration with Medtronic to develop deep brain stimulation treatment for numerous neurological disorders. The research team is trying to develop a new treatment method where the neural signals and biomechanical feedback from the patient are used to control the amount of stimulation a patient’s brain receives at any one time.
韩国先进科技研究所的研究人员开发了由智能手机控制的脑植入物。该设备的重要特点是它可以无线充电,这将有助于避免用于更换电池的周期性手术。这项研究于2021年1月在自然通信中公布。
The increasing number of aging people is also one of the important factors driving the growth of the global market for implants across the globe. According to estimation, globally there are more than 700 million persons aged above 65 and this number is expected to rapidly rise to 1.5 billion in 2050.
衰老与几种神经疾病有关,如帕金森和阿尔茨海默氏症。在全球范围内超过1000万人患有帕金森,超过90%的人以上超过50岁。估计有5000万人患有阿尔茨海默氏症的全世界。
由于全球神经治疗的延期,Covid-19大流行预计将在短期内略微阻碍植入物的全球市场增长。由于老年患者的Covid-19风险增加,许多人经历神经疗养学人员超过50岁,因此许多手术被推迟了患者在心中的安全性。即使在全球疫苗的批准,事情也需要几个月的时间。
该市场主要根据产品,申请和地区进行分段。
由产品 |
通过申请 |
按地区 |
|
|
|
了解有关此报告的更多信息:request for sample pages
The deep brain stimulator dominated the global brain implants market in 2020 and is expected to continue its domination during the forecast period. The increased usage in treating various neurological disorders makes the segment the highest shareholder of the global market as it offers a high rate of patient satisfaction and increased rate of patient survival.
The vagus nerve market segment is anticipated to witness the highest market growth rate during the forecast period. The introduction of new products with innovative technology and greater use in the treatment of various diseases including anxiety, migraines, obesity, and others is expected to drive the market segment growth in brain implants industry over the forecast period.
The chronic pain market segment accounted for the highest revenue share in 2020. A rise in the prevalence of chronic pain has heightened the need for long-lasting solutions in clinical practice. The use of medications to alleviate chronic pain is decreased by the use of a brain implant, as well as the improvement of neurological disorders.
Stimulators are used when surgery or other procedures have failed to alleviate severe neck or back pain. The need for these stimulators is growing due to the surge in chronic pain caused due to various conditions, which is further expected to fuel the market growth for brain implants.
Parkinson’s disease由于易患阿尔茨海默氏病和帕金森病的不断增长的老年人口,预计部分将成为预测期内的最快增长段。根据联合国经济和社会事务部,世界人口目前是77亿,并预计到2050年的97亿美元,鼓励未来几年的分部增长。
北美预计将在2020年占据全球市场,而由于新技术的适应性增加和神经系统障碍的发病率越来越大,预计将保持其优势。
目前,估计年龄人口在美国。S. is more than 50 million and is expected to reach nearly 100 million by 2060. The country has 5.5 million people suffering from Alzheimer’s. All these factors are expected to play a significant role in the region’s market growth for brain implants.
亚太大脑植入需求预计将witness substantial growth in the global market with increased affordability among patients with a significant rise in disposable income and rapidly evolving patient-centric healthcare facilities. Some of the fastest-growing economies such as China and India are expected to significantly propel the market growth for brain implants in the region.
There is a major increase in the research & development activities in brain implant devices since many major players are focusing to bring new devices to fulfill the unmet needs in neurological disorders. The companies are also trying to penetrate developing economies where there is huge revenue potential by launching new brain implant products.
Some of the major players operating in the global brain implants market include Boston Scientific Corporation, Medtronic, NeuroPace, Inc., Synapse Biomedical Inc., St. Jude Medical (Abbott), Nevro Corporation, and Aleva Neurotherapeutics SA.